Cochrane · systematic review · CD005625

Rutosides for treatment of post‐thrombotic syndrome

Morling, JR, Broderick, C, Yeoh, SE, et al. · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library

Vascular2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
12
current version
GRADE rated
6
No studies
6
Included studies
NR
No studies 6 · 50%Ungraded 0 · 0%Very low 0 · 0%Low 6 · 50%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Current version only

Rutosides versus placebo (or no treatment) for the treatment of post‐thrombotic syndrome

Population: patients with PTS
CD005625.PUB4 (current) · 4 questions
OutcomeEffectEvidenceStatus / GRADE
Occurrence of leg ulceration
Rutosides vs placebo (or no treatment)
no estimate extractedNRNo studies
Improvement in PTS (8 weeks ‐ 12 months)
Rutosides vs placebo (or no treatment)
OR 1.29 [0.69, 2.41]2 studies · 164 participantsLow
Downgraded: risk of bias, imprecision, publication bias
Deterioration in PTS (8 weeks ‐ 12 months)
Rutosides vs placebo (or no treatment)
OR 0.61 [0.19, 1.9]1 study · 80 participantsLow
Downgraded: risk of bias, imprecision, publication bias
Adverse effects (8 weeks ‐ 12 months)
Rutosides vs placebo (or no treatment)
no estimate extractedNRNo studies

Rutosides versus elastic compression stockings for the treatment of post‐thrombotic syndrome

Population: patients with PTS
CD005625.PUB4 (current) · 4 questions
OutcomeEffectEvidenceStatus / GRADE
Occurrence of leg ulceration
Rutosides vs elastic compression stockings
no estimate extractedNRNo studies
Improvement in PTS (12 months)
Rutosides vs elastic compression stockings
OR 0.8 [0.31, 2.03]1 study · 80 participantsLow
Downgraded: risk of bias, publication bias
Deterioration in PTS (12 months)
Rutosides vs elastic compression stockings
OR 0.61 [0.19, 1.9]1 study · 80 participantsLow
Downgraded: risk of bias, publication bias
Adverse effects (12 months)
Rutosides vs elastic compression stockings
no estimate extractedNRNo studies

Rutosides versus an alternative venoactive remedy (hidrosmina) for the treatment of post‐thrombotic syndrome

Population: patients with PTS
CD005625.PUB4 (current) · 4 questions
OutcomeEffectEvidenceStatus / GRADE
Occurrence of leg ulceration
Rutosides vs an alternative venoactive remedy (hidrosmina)
no estimate extractedNRNo studies
Improvement in PTS (6 months)
Rutosides vs an alternative venoactive remedy (hidrosmina)
OR 0.18 [0.04, 0.94]1 study · 29 participantsLow
Downgraded: risk of bias, imprecision, publication bias
Deterioration in PTS (6 months)
Rutosides vs an alternative venoactive remedy (hidrosmina)
OR 0.19 [0.01, 4.24]1 study · 29 participantsLow
Downgraded: risk of bias, imprecision, publication bias
Adverse effects
Rutosides vs an alternative venoactive remedy (hidrosmina)
no estimate extractedNRNo studies

Rutosides versus placebo or no comparator for the treatment of PTS

Population: People with post‐thrombotic syndrome
CD005625.PUB3 · 2 questions
OutcomeEffectEvidenceStatus / GRADE
Improvement in PTS
Rutosides vs placebo or no comparator
OR 1.29 [0.69, 2.41]2 studies · 164 participantsVery low
Downgraded: risk of bias
Deterioration in PTS
Rutosides vs placebo or no comparator
OR 0.61 [0.19, 1.9]1 study · 80 participantsVery low
Downgraded: risk of bias

Rutosides versus elastic compression stockings for the treatment of PTS

Population: People with post‐thrombotic syndrome
CD005625.PUB3 · 2 questions
OutcomeEffectEvidenceStatus / GRADE
Improvement in PTS
Rutosides vs elastic compression stockings
OR 0.8 [0.31, 2.03]1 study · 80 participantsLow
Downgraded: risk of bias
Deterioration in PTS
Rutosides vs elastic compression stockings
OR 0.61 [0.19, 1.9]1 study · 80 participantsLow
Downgraded: risk of bias

Rutosides versus hidrosmina for the treatment of PTS

Population: People with post‐thrombotic syndrome
CD005625.PUB3 · 2 questions
OutcomeEffectEvidenceStatus / GRADE
Improvement in PTS
Rutosides vs hidrosmina
OR 0.18 [0.04, 0.94]1 study · 29 participantsLow
Deterioration in PTS
Rutosides vs hidrosmina
OR 0.19 [0.01, 4.24]1 study · 29 participantsLow